Nirvana Life Sciences Inc. (CSE:NIRV)
0.0700
-0.0050 (-6.67%)
Jan 20, 2026, 9:04 AM EST
-86.00% (1Y)
| Market Cap | 1.60M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -375.89K |
| Shares Out | 22.92M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,000 |
| Average Volume | 5,581 |
| Open | 0.0700 |
| Previous Close | 0.0750 |
| Day's Range | 0.0700 - 0.0700 |
| 52-Week Range | 0.0300 - 0.3500 |
| Beta | -0.07 |
| RSI | 45.68 |
| Earnings Date | Mar 31, 2026 |